Influence of selective media on successful detection of shiga toxin-producing Escherichia coli in food, fecal, and environmental samples

Foodborne Pathogens and Disease

Volumn 5, Issue 3, 2008, Pages 227-244

  Hussein, Hussein S ^a   Bollinger, Laurie M ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM CULTURE; BACTERIUM DETECTION; CONTROLLED STUDY; CULTURE MEDIUM; FECES ANALYSIS; FOOD CONTAMINATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; CONSUMER PRODUCT SAFETY; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL MICROBIOLOGY; FECES; FOOD MICROBIOLOGY; SENSITIVITY AND SPECIFICITY; SHIGA-TOXIGENIC ESCHERICHIA COLI;

BOS; ESCHERICHIA COLI;

EID: 45749155973     PISSN: 15353141     EISSN: None     Source Type: Journal    
DOI: 10.1089/fpd.2008.0081     Document Type: Review

References (198)

1. Acheson DWK and Keusch GT. Which Shiga toxin-producing types of E. coli are important? ASM News 1996;62:302-306.
2. Allison LJ, Carter PE, and Thomson-Carter FM. Molecular epidemiology of Scottish E. coli O157 isolates - a three year study of phage type 28. Abstract from the 3rd International Symposium and Workshop on Shiga Toxin (Verocytotoxin)-Producing Escherichia coli Infections (VTEC 1997), Baltimore, MD, 1997.
3. Alonso JL, Amoros I, and Alonso MA. Differential susceptibility of aeromonads and coliforms to cefsulodin. Appl. Environ. Microbiol. 1996;62:1885-1888.
4. [AOAC] Association of Official Analytical Chemists. Official Methods of Analysis, 17th edition. Gaithersburg, MD: AOAC International, 2000.
5. Asakura H, Makino S, Shirahata T, Tsukamoto T, Kurazono H, Ikeda T, and Takeshi K. Detection and long-term existence of Shiga toxin (Stx)-producing Escherichia coli in sheep. Microbiol. Immunol. 1998;42:683-688.
6. Atlas MR and Park LC. Handbook of Microbiological Media, 2nd edition. Boca Raton, FL: CRC Press, 1997.
7. Baird R and Lee WH. Media used in the detection and enumeration of Staphylococcus aureus. Int. J. Food Microbiol. 1995;26:15-24.
8. Barkocy-Gallagher GA, Berry ED, Rivera-Betancourt M, Arthur TM, Nou X, and Koohmaraie M. Development of methods for the recovery of Escherichia coli O157:H7 and Salmonella from beef carcass sponge samples and bovine fecal and hide samples. J. Food Prot. 2002;65:1527-1534.
9. Barkocy-Gallagher GA, Edwards KK, Nou X, Bosilevac JM, Arthur TM, Shackelford SD, and Koohmaraie M. Methods for recovering Escherichia coli O157:H7 from cattle fecal, hide, and carcass samples: sensitivity and improvements. J. Food Prot. 2005;68:2264-2268.
10. Begg, EJ, Barclay ML, and Kirkpatrick CJ. The therapeutic monitoring of antimicrobial agents. Br. J. Clin. Pharmacol. 1999;47:23-30.
11. Bender JF, Schimpff SC, Young VM, Fortner CL, Brouillet MD, Love LJ, and Wiernik PH. Role of vancomycin as a component of oral nonabsorbable antibiotics for microbial suppression in leukemic patients. Antimicrob. Agents Chemother. 1979;15:455-460.
12. Bettelheim KA. Non-O157 verotoxin-producing Escherichia coli: a problem, paradox, and paradigm. Exp. Biol. Med. 2003;228:333-344.
13. Bettelheim KA. Serotypes of VTEC: the VTEC Table. Available at www.microbionet.com.au/vtectable.htm. Accessed December 31, 2007. Victoria, Australia: Sciencenet Multimedia Publishing House Pty. Limited, 2007.
14. Beutin L, Geier D, Zimmermann S, Aleksic S, Gillespie HA, and Whittam TS. Epidemiological relatedness and clonal types of natural populations of Escherichia coli strains producing Shiga toxins in separate populations of cattle and sheep. Appl. Environ. Microbiol. 1997;63:2175-2180.
15. Beutin L, Zimmermann S, and Gleier K. Evaluation of the VTEC-Screen "Seiken" test for detection of different types of Shiga toxin (verotoxin)-producing Escherichia coli (STEC) in human stool samples. Diagn. Microbiol. Infect. Dis. 2002;42:1-8.
16. Bhutta ZA, Khan JA, and Molla AM. Therapy of multidrug-resistant typhoid fever with oral cefixime vs. intravenous ceftriaxone. Pediatr. Infect. Dis. J. 1994;13:990-994.
17. Blais BW, Booth RA, Phillippe LM, and Yamazaki H. Effect of temperature and agitation on enrichment of Escherichia coli O157:H7 in ground beef using modified EC broth with novobiocin. Int. J. Food Microbiol. 1997;36:221-225.
18. Blanco JE, Blanco M, Alonso MP, Mora A, Dahbi G, Coira MA, and Blanco J. Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: prevalence in Lugo, Spain, from 1992 through 1999. J. Clin. Microbiol. 2004;42:311-319.
19. Blanco J, Blanco M, Blanco JE, Mora A, González EA, Bernárdez MI, Alonso MP, Coira A, Rodriguez A, Rey J, Alonso JM, and Usera MA. Verotoxin-producing Escherichia coli in Spain: prevalence, serotypes, and virulence genes of O157:H7 and non-O157 VTEC in ruminants, raw beef products, and humans. Exp. Biol. Med. 2003;228:345-351.
20. Bockemühl J, Aleksic S, and Karch H. Seriological and biochemical properties of Shiga-like toxin (verocytotoxin)-producing strains of Escherichia coli, other than O-group 157, from patients in Germany. Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis. 1992;276:189-195.
21. Bolton FJ, Crozier L, and Williamson JK. New technical approaches to Escherichia coli O157:H7. PHLS Microbiol. Dig. 1995;12:67-70.
22. Bonnet R, Souweine B, Gauthier G, Rich C, Livrelli V, Sirot J, Joly B, and Forestier C. Non-O157:H7 Stx2-producing Escherichia coli strains associated with sporadic cases of hemolytic-uremic syndrome in adults. J. Clin. Microbiol. 1998;36:1777-1780.
23. Boudailliez B, Berquin P, Mariani-Kurkdjian P, Ilef D, Cuvelier B, Capek I, Tribout B, Bingen E, and Piussan C. Possible person-to-person transmission of Escherichia coli O111-associated hemolytic uremic syndrome. Pediatr. Nephrol. 1997;11:36-39.
24. Bradley DE. Detection of tellurite-resistance determinants in IncP plasmids. J. Gen. Microbiol. 1985;131:3135-3137.
25. Bradley DE, Grewal KK, Taylor DE, and Whelan J. Characteristics of RP4 tellurite-resistance transposon Tn521. J. Gen. Microbiol. 1988;134:2009- 2018.
26. Brewster DH, Brown MI, Robertson D, Houghton GL, Bimson J, and Sharp JC. An outbreak of Escherichia coli O157 associated with a children's paddling pool. Epidemiol. Infect. 1994;112:441-447.
27. Brock TD. Studies on the mode of action of novobiocin. J. Bacteriol. 1956;72:320-323.
28. Brooks HJ, Mollison BD, Bettelheim KA, Matejka K, Paterson KA, and Ward VK. Occurrence and virulence factors of non-O157 Shiga toxin-producing Escherichia coli in retail meat in Dunedin, New Zealand. Lett. Appl. Microbiol. 2001;32:118-122.
29. Browning CH, Gulbransen R, and Thornton LHD. The antiseptic properties of acriflavine and proflavine and brilliant green. Br. Med. J. 1917;ii:70-75.
30. Bruce MG, Curtis MB, Payne MM, Gautom RK, Thompson EC, Bennett AL, and Kobayashi JM. Lake-associated outbreak of Escherichia coli O157:H7 in Clark County, Washington, August 1999. Arch. Pediatr. Adolesc. Med. 2003;157:1016-1021.
31. Catarame TMG, O'Hanlon KA, Duffy G, Sheridan JJ, Blair IS, and McDowell DA. Optimization of enrichment and plating procedures for the recovery of Escherichia coli O111 and O26 from minced beef. J. Appl. Microbiol. 2003;95:949-957.
32. Centers for Disease Control and Prevention. Epidemiological notes and reports foodborne outbreak of gastroenteritis caused by Escherichia coli O157:H7-North Dakota, 1990. Morb. Mortal. Wkly. Rep. 1991;40:265-267.
33. Centers for Disease Control and Prevention. 1993 foodborne disease outbreak line listing. Available at www.cdc.gov/foodborneoutbreaks/us_outb/ fbo1993/fbofinal1993.pdf, accessed February 20, 2007. Atlanta, GA: Centers for Disease Control and Prevention, 1993.
34. Centers for Disease Control and Prevention. Community outbreak of hemolytic uremic syndrome attributable to Escherichia coli O111:NM-South Australia, 1995. Morb. Mortal. Wkly. Rep. 1995;44:550-551, 557-558.
35. Centers for Disease Control and Prevention. Reduced susceptibility of Staphylococcus aureus to vancomycin-Japan, 1996. Morb. Mortal. Wkly. Rep. 1997;46:624-626.
36. Centers for Disease Control and Prevention. 1999 foodborne disease outbreak line listing. Available at www.cdc.gov/foodborneoutbreaks/us_outb/ fbo1999/fbofinal1999.pdf, accessed February 20, 2007. Atlanta, GA: Centers for Disease Control and Prevention, 1999.
37. Centers for Disease Control and Prevention. Outbreak of Escherichia coli O157:H7 infection associated with eating fresh cheese curds-Wisconsin, June 1998. Morb Mortal Wkly Rep. 2000;49:911-913.
38. Centers for Disease Control and Prevention. 2002 Foodborne disease outbreaks due to bacterial etiologies. Available at www.cdc.gov/ foodborneoutbreaks/us_outb/fbo2002/2002linelist.pdf, accessed February 20, 2007. Atlanta, GA: Centers for Disease Control and Prevention, 2002a.
39. Centers for Disease Control and Prevention. Guidelines for treatment of sexually transmitted diseases 2002. Morb. Mortal. Wkly. Rep. 2002b;51:1-82.
40. Centers for Disease Control and Prevention. E. coli O157 outbreak summaries. Available at www.cdc.gov/foodborneoutbreaks/us_outb/fbo2003/ 2003LineList.pdf, accessed February 20, 2007. Atlanta, GA: Centers for Disease Control and Prevention, 2003.
41. Centers for Disease Control and Prevention. Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach - United States, September 2006. Morb. Mortal. Wkly. Rep. 2006;55:1045-1046.
42. Chapman PA, Cerdán Malo AT, Ellin M, Ashton R, and Harkin MA. Escherichia coli O157 in cattle and sheep at slaughter, on beef and lamb carcasses and in raw beef and lamb products in South Yorkshire, UK. Int. J. Food Microbiol. 2001;64:139-150.
43. Chapman PA, Christine A, Siddons A, Zadik PM, and Jewes L. An improved selective medium for the isolation of Escherichia coli O157. J. Med. Microbiol. 1991;35:107-110.
44. Chapman PA and Siddons CA. Evaluation of a commercial enzyme immunoassay (EHEK-Tek) for detecting Escherichia coli O157:H7 in beef and beef products. Food Microbiol. 1996;13:175-182.
45. Cieslak PR, Barrett TJ, and Griffin PM. Escherichia coli O157:H7 infection from a manured garden. Lancet 1993;342:367.
46. Cloak O, Duffy G, Sheridan JJ, Blair IS, and McDowell DA. Isolation and detection of Listeria spp., Salmonella spp. and Yersinia spp. using a simultaneous enrichment step followed by a surface adhesion immunofluorescent technique. J. Microbiol. Methods 1999;39:33-43.
47. Conradi H and Troch P. Ein Verfahren zum Nachweis der Diphtheriebazillen. Muench. Med. Wochenschr. 1912;59:1652-1653 (German).
48. Crump JA, Langer AJ, Gage R, Baysinger M, Withers G, Toney DM, Hunter SB, Hoekstra M, Wong SK, Griffin PM, and Van Gilder TJ. An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm. N. Engl. J. Med. 2002;347:555-560.
49. Cui S, Schroeder CM, Zhang DY, and Meng J. Rapid sample preparation method for PCR-based detection of Escherichia coli O157:H7 in ground beef. J. Appl. Microbiol. 2003;95:129-134.
50. Dargatz DA, Wells SJ, Thomas LA, Hancock DD, and Garber LP. Factors associated with the presence of Escherichia coli O157 in feces of feedlot cattle. J. Food Prot. 1997;60:466-470.
51. de Hoog M, Mouton JW, and van den Anker JN. Vancomycin: Pharmacokinetics and administration regimens in neonates. Clin. Pharmacokinet. 2004;43:417-440.
52. Doyle MP and Schoeni JL. Isolation of Escherichia coli O157:H7 from retail fresh meats and poultry. Appl. Environ. Microbiol. 1987;53:2394-2396.
53. Eisenberg P. Untersuchungen über spezifische Desinfektionsvorgä nge. II. Mitteilung: Ueber die Wirkung von Salzen und Ionen auf Bakterien. Zentralbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt. 1919;1: Orig. 82:69-208 (German).
54. Elder RO, Keen JE, Siragusa GR, Barkocy-Gallagher GA, Koohmaraie M, and Laegreid WW. Correlation of enterohemorrhagic Escherichia coli O157 prevalence in feces, hides, and carcasses of beef cattle during processing. Proc. Natl. Acad. Sci. U S A. 2000;97:2999-3003.
55. Faith NG, Shere JA, Brosch R, Arnold KW, Ansay SE, Lee MS, Luchansky JB, and Kaspar CW. Prevalence and clonal nature of E. coli O157:H7 on dairy farms in Wisconsin. Appl. Environ. Microbiol. 1996;62:1519-1525.
56. [FDA] Food and Drug Administration. Food and Drug Administration Bacteriological Analytical Manual, 8th edition. Rockville, MD, 1998.
57. Finland M and Nichols RL. Novobiocin. Antibiot. Chemother. 1957;4:209-392.
58. Fishbein M. The aerogenic response of Escherichia coli and strains of Aerobacter in EC broth and selected sugar broths at elevated temperatures. Appl. Microbiol. 1962;10:79-85.
59. Fleming A. On the specific antibacterial properties of penicillin and potassium tellurite. J. Pathol. Bacteriol. 1932;35:831-842.
60. Fleming A and Young MY. The inhibitory action of potassium tellurite on coliform bacteria. J. Pathol. Bacteriol. 1940;51:29-35.
61. Foster G, Hopkins GF, Gunn GJ, Ternent HE, Thomson-Carter F, Knight HI, Graham DJL, Edge V, and Synge BA. A comparison of two pre-enrichment media prior to immunomagnetic separation for the isolation of E. coli O157 from bovine faeces. J. Appl. Microbiol. 2003;95:155-159.
62. Fratamico PM and Bagi LK. Comparison of methods for detection and isolation of cold- and freeze-stressed Escherichia coli O157:H7 in raw ground beef. J. Food Prot. 2007;70:1663-1669.
63. Fukushima H and Gomyoda M. Hydrochloric acid treatment for rapid recovery of Shiga toxin-producing Escherichia coli O26, O111 and O157 from faeces, food and environmental samples. Zentralbl. Bakteriol. 1999a;289:285-299.
64. Fukushima H and Gomyoda M. An effective, rapid and simple method for isolation of Shiga toxin-producing Escherichia coli O26, O111 and O157 from feces and food samples. Zentralbl. Bakteriol. 1999b;289:415-428.
65. Fukushima H, Hoshina K, and Gomyoda M. Selective isolation of eae-positive strains of Shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 2000;38:1684-1687.
66. Galland JC, Hyatt DR, Crupper SS, and Acheson DW. Prevalence, antibiotic susceptibility, and diversity of Escherichia coli O157:H7 isolates from a longitudinal study of beef cattle feedlots. Appl. Environ. Microbiol. 2001;67:1619-1627.
67. Ge B, Larkin C, Ahn S, Jolley M, Nasir M, Meng J, and Hall RH. Identification of Escherichia coli O157:H7 and other enterohemorrhagic serotypes by EHEC-HlyA targeting, strand displacement amplification, and fluorescence polarization. Mol. Cell Probes 2002;16:85-92.
68. Gellert M, O'Dea MH, Itoh T, and Tomizawa J. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase. Proc. Natl. Acad. Sci. U S A. 1976;73:4474-4478.
69. Girgis NI, Sultan Y, Hammad O, and Farid Z. Comparison of the efficacy, safety, and cost of cefixime, ceftriaxone, and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children. Pediatr. Infect. Dis. J. 1995;14:603-605.
70. Griffin PM and Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol. Rev. 1991;13:60-98.
71. Grondeau C, Manceau C, and Samson R. A semiselective medium for the isolation of Acidovorax valerianellae from soil and plant debris. Plant Pathol. 2007;56:302-310.
72. Guerini MN, Bosilevac JM, and Koohmaraie M. Rapid enrichment strategy for isolation of Listeria from bovine hide, carcass, and meat samples. J. Food Prot. 2007;70:53-57.
73. Gunn GJ, McKendrick IJ, Ternent HE, Thomson-Carter F, Foster G, and Synge BA. An investigation of factors associated with the prevalence of verocytotoxin producing Escherichia coli O157 shedding in Scottish cattle. Vet. J. 2007;174:554-564.
74. Hancock DD, Besser TE, Kinsel ML, Tarr PI, Rice DH, and Paros MG. The prevalence of Escherichia coli O157:H7 in dairy and beef cattle in Washington State. Epidemiol. Infect. 1994;113:199-207.
75. Hara-Kudo Y, Konuma H, Nakagawa H, and Kumagai S. Escherichia coli O26 detection from foods using an enrichment procedure and an immunomagnetic separation method. Lett. Appl. Microbiol. 2000;30:151-154.
76. Hara-Kudo Y, Onoue Y, Konuma H, Nakagawa H, and Kumagai S. Comparison of enrichment procedures for isolation of Escherichia coli O157:H7 from ground beef and radish sprouts. J. Food Microbiol. 1999;50:211-214.
77. Hepburn NF, MacRae M, Johnston M, Mooney J, and Ogden ID. Optimizing enrichment conditions for the isolation of Escherichia coli O157 in soils by immunomagnetic separation. Lett. Appl. Microbiol. 2002;34:365-369.
78. Herriott DE, Hancock DD, Keene WE, and Rice DH. Raw milk associated E. coli O157:H7 outbreaks in Oregon. Proceedings from the 8th International Congress on Animal Hygiene, International Society of Animal Hygiene Meeting, St. Paul, MN, 1994.
79. Herwaldt L, Boyken L, and Pfaller M. in vitro selection of resistance to vancomycin in bloodstream isolates of Staphylococcus haemolyticus and Staphylococcus epidermidis. Eur. J. Clin. Microbiol. Infect. Dis. 1991;10:1007-1012.
80. Heuvelink AE, van den Biggelaar FLAM, de Boer E, Herbes RG, Melchers WJG, Huis In 'T Veld JHJ, and Monnens LAH. Isolation and characterization of verocytotoxin-producing E. coli O157 strains from Dutch cattle and sheep. J. Clin. Microbiol. 1998;36:878-882.
81. Hiramatsu R, Matsumoto M, Miwa Y, Suzuki Y, Saito M, and Miyazaki Y. Characterization of Shiga toxin-producing Escherichia coli O26 strains and establishment of selective isolation media for these strains. J. Clin. Microbiol. 2002;40:922-925.
82. Hoeprich PD, Croft GF, and West LM. Tellurite reduction as an indicator of potentially pathogenic staphylococci. J. Lab. Clin. Med. 1960;55:120- 128.
83. Hussein HS. Prevalence and pathogenicity of Shiga toxin-producing Escherichia coli in beef cattle and their products. J. Anim. Sci. 2007;85:E63-E72.
84. Hussein HS, Bollinger LM, and Hall MR. Growth and enrichment medium for the detection and isolation of Shiga toxin-producing Escherichia coli in cattle feces. J. Food Prot. 2008; (in press).
85. Hussein HS and Sakuma T. Prevalence of Shiga toxin-producing Escherichia coli in dairy cattle and their products. J. Dairy Sci. 2005;88:450-465.
86. Islam MA, Heuvelink AE, Talukder KA, and de Boer E. Immunoconcentration of Shiga toxin-producing Escherichia coli O157 from animal faeces and raw meats by using Dynabeads anti-E. coli O157 and the VIDAS system. Int. J. Food Microbiol. 2006;109:151-156.
87. Jinneman KC, Trost PA, Hill WE, Weagant SD, Bryant JL, Kaysnet CA, and Wekell MM. Comparison of template preparation methods from foods for amplification of Escherichia coli O157 Shiga-like toxin type I and II DNA by multiplex polymerase chain reaction. J. Food Prot. 1995;58:722-726.
88. Johnson JL, Rose BE, Sharar AK, Ransom GM, Lattuada CP, and McNamara AM. Methods used for detection and recovery of Escherichia coli O157:H7 associated with a foodborne disease outbreak. J. Food Prot. 1995;58:597.
89. Jones IG and Roworth M. An outbreak of Escherichia coli O157 and campylobacteriosis associated with contamination of a drinking water supply. Public Health 1996;110:277-282.
90. Karch H, Janetzki-Mittmann C, Aleksic S, and Datz M. Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic uremic syndrome by using immunomagnetic separation, DNA-based methods and direct culture. J. Clin. Microbiol. 1996;34:516-519.
91. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, and Lior H. The association between idiopathic hemolytic-uremic syndrome and infection by verotoxin-producing Escherichia coli. J. Infect. Dis. 1985;151:775-782.
92. Keene WE, McAnulty JM, Hoesly FC, Williams LP, Hedberg K, Oxman GL, Barrett TJ, Pfaller MA, and Fleming DW. A swimming-associated outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7 and Shigella sonnei. N. Engl. J. Med. 1994;331:579-584.
93. Khaitsa ML, Bauer ML, Gibbs PS, and Lardy GP. Risk assessment of Escherichia coli O157:H7 fecal shedding in North Dakota feedlot cattle. In: Unified Beef Cattle and Range Research Report. Fargo, ND: North Dakota State University, 2003, pp. 34-36.
94. Kim MS and Doyle MP. Dipstick immunoassay to detect enterohemorrhagic Escherichia coli O157:H7 in retail ground beef. Appl. Environ. Microbiol. 1992;59:1764-1767.
95. Kirby WM, Hudson DG, and Noyes WD. Clinical and laboratory studies of novobiocin, a new antibiotic. AMA Arch. Intern. Med. 1956;98:1-7.
96. Kobayashi H, Shimada J, Nakazawa M, Morozumi T, Pohjanvirta T, Pelkonen S, and Yamamoto K. Prevalence and characteristics of Shiga toxin-producing Escherichia coli from healthy cattle in Japan. Appl. Environ. Microbiol. 2001;67:484-489.
97. Konowalchuk J, Speirs JI, and Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect. Immun. 1977;18:775-779.
98. Krishnan C, Fitzgerald VA, Dakin SJ, and Behme RJ. Laboratory investigation of outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7. J. Clin. Microbiol. 1987;25:1043-1047.
99. Lahti E, Eklund M, Ruutu P, Siitonen A, Rantala L, Nuorti P, and Honkanen-Buzalski T. Use of phenotyping and genotyping to verify transmission of Escherichia coli O157:H7 from dairy farms. Eur. J. Clin. Microbiol. Infect. Dis. 2002;21:189-195.
100. Lehmacher A, Meier H, Aleksic S, and Bockemühl J. Detection of hemolysin variants of Shiga toxin-producing Escherichia coli by PCR and culture on vancomycin-cefixime-cefsulodin blood agar. Appl. Environ. Microbiol. 1998;64:2449-2453.
101. LeJeune JT, Besser TE, Rice DH, Berg JL, Stilborn RP, and Hancock DD. Longitudinal study of fecal shedding of Escherichia coli O157:H7 in feedlot cattle: predominance and persistence of specific clonal types despite massive cattle population turnover. Appl. Environ. Microbiol. 2004;70:377-384.
102. Leomil L, Aidar-Ugrinovich L, Guth BEC, Irino K, Vettorato MP, Onuma DL, and de Castro AFP. Frequency of Shiga toxin-producing Escherichia coli (STEC) isolates among diarrheic and non-diarrheic calves in Brazil. Vet. Microbiol. 2003;97:103-109.
103. Lerman LS. Structural considerations in the interaction of DNA and acridines. J. Mol. Biol. 1961;3:18-30.
104. Lerman LS. The structure of the DNA-acridine complex. Proc. Natl. Acad. Sci. U S A. 1963;49:94-102.
105. Leung PHM, Yam WC, Ng WWS, and Peiris JSM. The prevalence and characterization of verotoxin-producing Escherichia coli isolated from cattle and pigs in an abattoir in Hong Kong. Epidemiol. Infect. 2001;126:173-179.
106. Lim KS, Huh CS, and Baek YJ. Antimicrobial susceptibility of bifidobacteria. J. Dairy Sci. 1993;76:2168-2174.
107. Lionberg WC, Restaino L, Framptonand EW, and Barbour WM. Efficacy of enrichment broths in the recovery of freeze-injured Escherichia coli O157:H7 in inoculated ground beef by PCR. J. Food Prot. 2003;66:1911- 1915.
108. Lior H. Classification of Escherichia coli. In: Escherichia coli in Domestic Animals and Humans. Gyles CL (ed). CAB International, Wallingford, UK, 1994, pp. 31-72.
109. Liu P, Rand KH, Obermann B, and Derendorf H. Pharmacokinetic- pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kineticmodels. Int. J. Antimicrob. Agents 2005;25:120-129.
110. López EL, Contrini MM, Sanz M, Viñas MR, Parma A, De Rosa MF, and Cleary TG. Perspectives in Shiga-like toxin infections in Argentina. J. Food Prot. 1997;60:1458-1462.
111. Low DA, Braaten BA, Ling GV, Johnson DL, and Ruby AL. Isolation and comparison of Escherichia coli strains from canine and human patients with urinary tract infections. Infect. Immun. 1988;56:2601-2609.
112. Lu JJ, Lee SY, and Perng CL. Proficiency of determination of vancomycin susceptibility in enterococci by clinical laboratories in Taiwan. J. Microbiol. Immunol. Infect. 2004;37:242-245.
113. March SB and Ratnam S. Sorbitol-MacConkey medium for the detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. J. Clin. Microbiol. 1986;23:869-872.
114. McCarthy J, Holbrook R, and Stephens PJ. An improved direct plating method for the enumeration of stressed Escherichia coli O157:H7 from foods. J. Food Prot. 1998;61:1093-1097.
115. McEvoy JM, Doherty AM, Sheridan JJ, Thomson-Carter FM, Garvey P, McGuire L, Blair IS, and McDowell DA. The prevalence and spread of Escherichia coli O157:H7 at a commercial beef abattoir. J. Appl. Microbiol. 2003;95:256-266.
116. McKee R, Madden RH, and Gilmour A. Occurrence of verocytotoxin-producing Escherichia coli in dairy and meat processing environments. J. Food Prot. 2003;66:1576-1580.
117. Meyer A, Deiana J, and Leclerc H. Cours de Microbiologie Générale. Paris, France: Jouve, 1995 (French).
118. Mitsuhashi S, Morimura M, Kono K, and Oshima H. Elimination of drug resistanceof Staphylococcus aureus by treatment with acriflavine. J. Bacteriol. 1963;86:162-164.
119. Moreira CN, Pereira MA, Brod CS, Rodrigues DP, Carvalhal JB, and Aleixo JAG. Shiga toxin-producing Escherichia coli (STEC) isolated from healthy dairy cattle in southern Brazil. Vet. Microbiol. 2003;93:179-183.
120. Morgan D, Newman CP, Hutchinson DN, Walker AM, Rowe B, and Majid F. Verotoxin producing Escherichia coli O157 infections associated with the consumption of yoghurt. Epidemiol. Infect. 1993;111:181-187.
121. Murinda SE, Batson SD, Ngyuen LT, Gillespie BE, and Oliver SP. Phenotypic and genetic markers for serotype-specific detection of Shiga toxin-producing Escherichia coli O26 strains from North America. Foodborne Pathog. Dis. 2004;1:125-135.
122. Murinda SE, Nguyen LT, Ivey SJ, Gillespie BE, Almeida RA, Draughon FA, and Oliver SP. Prevalence and molecular characterization of Escherichia coli O157:H7 in bulk tank milk and fecal samples from cull cows: A 12-month survey of dairy farms in East Tennessee. J. Food Prot. 2002;65:752-759.
123. Nauta MJ and Dufrenne J. Variability in growth characteristics of different E. coli O157:H7 isolates, and its implications for predictive microbiology. Quant. Microbiol. 1999;1:137-155.
124. Neill MA. Overview of Verotoxigenic Escherichia coli. J. Food Prot. 1997;60:1444-1446.
125. Neu HC. in vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime. Pediatr. Infect. Dis. J. 1987;6:958-962.
126. Neu HC, Geiss HK, Marinescu M, Rigby A, Robinson J, and Altwegg M. Media and methods for isolation of aeromonads from fecal specimens. A multilaboratory study. Experientia 1991;47:409-412.
127. Oberst RD, Hays MP, Bohra LK, Phebus RK, Yamashiro CT, Paszko-Kolva C, Flood SJA, Sargeant JM, and Gillespie JR. PCR-based DNA amplification and presumptive detection of Escherichia coli O157:H7 with an internal fluorogenic probe and the 5′ nuclease (TaqMan) assay. Appl. Environ. Microbiol. 1998;64:3389-3396.
128. O'Brien AD and Holmes RK. Shiga and Shiga-like toxins. Microbiol. Rev. 1987;51:206-220.
129. O'Brien AD and LaVeck GD. Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli. Infect. Immun. 1983;40:675-683.
130. O'Hanlon KA, Catarame TMG, Duffy G, Blair IS, and McDowell DA. Rapid detection and quantification of E. coli O157/O26/O111 in minced beef by real-time PCR. J. Appl. Microbiol. 2004;96:1013-1023.
131. Olsen SJ, Miller G, Breuer T, Kennedy H, Higgins C, Walford J, McKee G, Fox K, Bibb W, and Mead P. A waterborne outbreak of Escherichia coli O157:H7 infections and hemolytic uremic syndrome: implications for rural water systems. Emerg. Infect. Dis. 2002;8:370-375.
132. Onoue Y, Konuma H, Nakagawa H, Hara-Kudo Y, Fujita T, and Kumagai S. Collaborative evaluation of detection method for Escherichia coli O157:H7 from radish sprout and ground beef. Int. J. Food Microbiol. 1999;46:27-36.
133. Orden JA, Cid D, Ruiz-Santa-Quireria JA, García S, Martínez S, and de la Fuente R. Verotoxin-producing Escherichia coli (VTEC), enteropathogenic E. coli (EPEC) and necrotoxigenic E. coli (NTEC) isolated from healthy cattle in Spain. J. Appl. Microbiol. 2002;93:29-35.
134. Owens Jr RC, Tessier P, Nightingale CH, Ambrose PG, Quintiliani R, and Nicolau DP. Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens. Int. J. Antimicrob. Agents 2001;17:483-489.
135. Padhye NV and Doyle MP. Rapid procedure for detecting enterohemorrhagic Escherichia coli O157:H7 in food. Appl. Environ. Microbiol. 1991;57:2693-2698.
136. Pai CH, Gordon R, Sims HV, and Bryan LE. Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features. Ann. Intern. Med. 1984;101:738-742.
137. Pao S, Patel D, Kalantari A, Tritschler JP, Wildeus S, and Sayre BL. Detection of Salmonella strains and Escherichia coli O157:H7 in feces of small ruminants and their isolation with various media. Appl. Environ. Microbiol. 2005;71:2158-2161.
138. Paton JC and Paton AQ. Shiga toxigenic Escherichia coli infections. Sci. Med. 2000;May/June:28-37.
139. Paton AW, Ratcliff RM, Doyle MR, Seymour-Murray J, Davos D, Lancer JA, and Paton JC. Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli. J. Clin. Microbiol. 1996;34:1622-1627.
140. Pradel N, Boukhors K, Bertin Y, Forestier C, Martin C, and Livrelli V. Heterogeneity of Shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients, cattle, and food samples in central France. Appl. Environ. Microbiol. 2001;67:2460-2468.
141. Pradel N, Livrelli V, De Champs C, Palcoux JB, Reynaud A, Scheutz F, Sirot J, Joly B, and Forestier C. Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France. J. Clin. Microbiol. 2000;38:1023-1031.
142. Public Health Laboratory Service. Vero cytotoxin-producing Escherichia coli O157: 2001. Available at http://www.hpa.org.uk/cdr/. Commun. Dis. Rep. CDR Wkly. 2002;12(24).
143. Rappaport F and Henig E. Media for the isolation and differentiation of pathogenic Escherichia coli serotypes O111 and O55. J. Clin. Pathol. 1952;5:361-362.
144. Rahaman MM, Morshed MG, Sultanul Aziz KM, and Munshi MM. Improved medium for isolating Shigella. Lancet 1986;i:271-272.
145. Ratnam S, March SB, Ahmed R, Bezanson GS, and Kasatiya S. Characterization of Escherichia coli serotype O157:H7. J. Clin. Microbiol. 1988;26:2006-2012.
146. Reid TMS. A case study of cheese associated E. coli O157 outbreaks in Scotland. In: Verocytotoxigenic Escherichia coli. Duffy G, Garvey P, and McDowell D (eds). Trumbull, CT; Food and Nutrition Press Inc., 2001, pp. 201-212.
147. Reida P, Wolff M, Pohls HW, Kuhlmann W, Lehmacher A, Aleksic S, Karch H, and Bockemuhl J. An outbreak due to enterohemorrhagic Escherichia coli O157:H7 in a children day care center characterized by person-to-person transmission and environmental contamination. Zentralbl. Bakteriol. 1994;281:534-543.
148. Remis RS, MacDonald KL, Riley LW, Puhr ND, Wells JG, Davis BR, Blake PA, and Cohen ML. Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Ann. Intern. Med. 1984;101:624-626.
149. Ren J, Utsunomiya I, Taguchi K, Ariga T, Tai T, Ihara Y, and Miyatake T. Localization of verotoxin receptors in nervous system. Brain Res. 1999;825:183-188.
150. Renter DG, Sargeant JM, Oberst RD, and Samadpour M. Diversity, frequency, and persistence of Escherichia coli O157 strains from range cattle environments. Appl. Environ. Microbiol. 2003;69:542-547.
151. Restaino L, Castillo HL, Stewart D, and Tortorello ML. Antibody-directed epiflourescent filter technique and immunomagnetic separation for 10 h screening and 24 h confirmation of Escherichia coli O157:H7 in beef. J. Food Prot. 1996;59:1072-1075.
152. Restaino L, Frampton EW, Irbe RM, and Allison DRK. A 5-h screening and 24-h confirmation procedure for detecting Escherichia coli O157:H7 in beef using direct epifluorescent microscopy and immunomagnetic separation. Lett. Appl. Microbiol. 1997;24:401-404.
153. Riley LW, Remis RS, Helgerson SD, McGee HB, Well JG, Davis BR, Hebert RJ, Olcott ES, Johnson LM, Hargrett NT, Blake PA, and Cohen ML. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 1983;308:681-685.
154. Sanchez-Romero JM, Diaz-Orejas R, and De Lorenzo V. Resistance to tellurite as a selection marker for genetic manipulations of Pseudomonas strains. Appl. Environ. Microbiol. 1998;64:4040-4046.
155. Santillán MA, D'Aquino M, and Franco MA. Effect of different dairy products on the growth of Listeria monocytogenes in selective media. Rev. Argent. Microbiol. 1997;29:63-67.
156. Sata S, Fujisawa T, Osawa R, Iguchi A, Yamai S, and Shimada T. An improved enrichment broth for isolation of Escherichia coli O157, with specific reference to starved cells, from radish sprouts. Appl. Environ. Microbiol. 2003;69:1858-1860.
157. Schatz BS, Karavokiros KT, Taeubel MA, and Itokazu GS. Comparison of
158. Sealy L, Cotten M, and Chalkley R. Novobiocin inhibits passive chromatin assembly in vitro. EMBO J. 1986;5:3305-3311.
159. Sekla L, Milley D, Stackiw W, Sisler J, Drew J, and Sargent D. Verotoxin-producing Escherichia coli in ground beef-Manitoba. Can. Dis. Wkly. Rep. 1990;16:103-105.
160. Shigi Y, Matsumoto Y, Kaizu M, Fujishita Y, and Kojo H. Mechanism of action of the new orally active cephalosporin FK027. J. Antibiot. 1984;37:790-796.
161. Shimada T, Sakazaki R, Fujimura S, Niwano K, Mishina M, and Takizawa K. A new selective, differential agar medium for isolation of Vibrio cholerae O1:PMT (polymyxin mannose-tellurite) agar. Jpn. J. Med. Sci. Biol. 1990;43:37-41.
162. Shinagawa K. Correspondence and problem for Enterohemorrhagic E. coli O157 outbreak in Morioka City, Iwate. Koshu Eisei Kenkyu 1997;46:104-112.
163. Shinagawa K, Kanehira M, Omoe K, Matsuda I, Hu D-L, Widiasih DA, and Sugii S. Frequency of Shiga toxin-producing Escherichia coli in cattle at a breeding farm and at a slaughterhouse in Japan. Vet. Microbiol. 2000;76:305-309.
164. Shockman GD and Lampen JO. Inhibition by antibiotics of the growth of bacterial and yeast protoplasts. J. Bacteriol. 1962;84:508-512.
165. Skadhauge K. Studies on Enterococci with Special Reference to the Serological Properties. Monograph. Copenhagen, Denmark: Einar Munksgaa Forlag, 1950.
166. Slack MPE, Wheldon DB, Swann RA, and Perks E. Cefsulodin, a cephalosporin with specific antipseudomonal activity; in vitro studies of the drug alone and in combination. J. Antimicrob. Chemother. 1979;5:687-691.
167. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, and Jarvis WR. Emergence of vancomycin resistance in Staphylococcus aureus: glycopeptide-intermediate Staphylococcus aureus working group. N. Engl. J. Med. 1999;340:493-501.
168. Stefani S, Pellegrino MB, D'Amico G, Privitera A, Privitera O, Maccarrone G, Russo G, and Nicoletti G. in vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae. Chemotherapy 1992;38:36-45.
169. Steffensky M, Muhlenweg A, Wang ZX, Li SM, and Heide L. Identification of the novobiocin biosynthetic gene cluster of Streptomyces spheroides NCIB 11891. Antimicrob. Agents Chemother. 2000;44:1214-1222.
170. Stevens DL. The role of vancomycin in the treatment paradigm. Clin. Infect. Dis. 2006;42:S51-S57.
171. Sultan T, Baltch AL, Smith RP, and Ritz W. in vitro activity of cefdinir (FK482) and ten other antibiotics against gram-positive and gram-negative bacteria isolated from adult and pediatric patients. Chemotherapy 1994;40:80-91.
172. Then RL and Angehrn P. Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism. Antimicrob. Agents Chemother. 1982;21:711-717.
173. Thompson JS, Hodge DS, and Borczyk AA. Rapid biochemical test to identify verocytotoxin-positive strains of Escherichia coli serotype O157. J. Clin. Microbiol. 1990;28:2165-2168.
174. Toshima H, Uenaka E, Bi Y, Nakamura H, Ogasawara J, Hase A, Kamata Y, and Nishikawa Y. Detection and isolation of Escherichia coli with a coding gene for enteroaggregative Escherichia coli heat-stable enterotoxin 1 from food and comparison with fecal isolates. J. Food Prot. 2004;67:2117- 2122.
175. Turner RJ, Weiner JH, and Taylor DE. The tellurite resistance determinants tehAtehB and klaAklaBtelB have different biochemical requirements. Microbiology 1995;141:3133-3140.
176. Uemura R, Sueyoshi M, Nagayoshi M, and Nagatomo H. Antimicrobial susceptibilities of Shiga toxin-producing Escherichia coli isolates from pigs with edema disease in Japan. Microbiol. Immunol. 2003;47:57-61.
177. U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services. Escherichia coli O157:H7 in U.S. Dairy Calves. January Report, National Animal Health Monitoring System. Fort Collins, CO: U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services, Centers for Epidemiology and Animal Health, 1994.
178. U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services. An update: Escherichia coli O157:H7 in humans and cattle. Fort Collins, CO: USDA Animal and Plant Health Inspection Service, Veterinary Service, Centers for Epidemiology and Animal Health, 1997.
179. Varaldo PE, Debbia E, and Schito GC. In vitro activity of teichomycin and vancomycin alone and in combination with rifampin. Antimicrob. Agents Chemother. 1983;23:402-406.
180. Varela-Hernández JJ, Cabrera-Diaz E, Cardona-López MA, Ibarra-Velázquez LM, Rangel-Villalobos H, Castillo A, Torres-Vitela MR, and Ramírez-Álvarez A. Isolation and characterization of Shiga toxin-producing Escherichia coli O157:H7 and non-O157 from beef carcasses at a slaughter plant in Mexico. Int. J. Food Microbiol. 2006;113:237- 241.
181. Vernozy-Rozand C and Ray-Gueniot S. Escherichia coli O157:H7 et Escherichia coli Verotoxiques: particularités physiologiques, biochimiques, méthodes d'isolement et de détection dans les aliments. Méd Vét. 1997;2:148 (French).
182. Vimont A, Delignette-Muller M-L, and Vernozy-Rozand C. Supplementation of enrichment broths by novobiocin for detecting Shiga toxin-producing Escherichia coli from food: a controversial use. Lett. Appl. Microbiol. 2007;44:326-331.
183. Vimont A, Vernozy-Rozand C, Montet MP, Lazizzera C, Bavai C, and Delignette-Muller ML. Modeling and predicting the simultaneous growth of Escherichia coli O157:H7 and ground beef background microflora for various enrichment protocols. Appl. Environ. Microbiol. 2006;72:261-268.
184. Walter EG and Taylor DE. Plasmid-mediated resistance to tellurite: expressed and cryptic. Plasmid 1992;27:52-64.
185. Walter EG, Thomas CM, Ibbotson JP, and Taylor DE. Transcriptional analysis, translational analysis, and sequence of the kilA-tellurite resistance region of plasmid RK2Ter. J. Bacteriol. 1991;173:1111-1119.
186. Weagant SD and Bound AJ. Evaluation of techniques for enrichment and isolation of Escherichia coli O157:H7 from artificially contaminated sprouts. Int. J. Food Microbiol. 2001;71:87-92.
187. Weagant SD, Bryant JL, and Jinneman KG. An improved rapid technique for isolation of Escherichia coli O157 from foods. J. Food Prot. 1995;58:7-12.
188. Webb ML, Maguire KA, and Jacob ST. Novobiocin inhibits initiation of RNA polymerase II-directed transcription of the mouse metallothionein-I gene independent of its effect on DNA topoisomerase II. Nucleic Acids Res. 1987;15:8547-8560.
189. Wells JG, Davis BR, Wachsmuth IK, Riley LW, Remis RS, Sokolow R, and Morris GK. Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. J. Clin. Microbiol. 1983;18:512-520.
190. Werber D, Fruth A, Liesegang A, Littmann M, Buchholz U, Prager R, Karch H, Breuer T, Tschape H and Ammon A. A multistate outbreak of Shiga toxin-producing Escherichia coli O26:H11 infections in Germany, detected by molecular subtyping surveillance. J. Infect. Dis. 2002;186:419-422.
191. Willshaw GA, Scotland SM, and Rowe B. Verocytotoxin-producing Escherichia coli. In: Escherichia coli: Mechanisms of Virulence. Sussman, M. (ed), Cambridge, UK: Cambridge University Press, 1997, pp. 421-448.
192. Wise R, Andrews JM, Ashby JP, and Thornder D. in vitro activity of Bay v 3522, a new cephalosporin, compared with activities of other agents. Antimicrob. Agents Chemother. 1990;34:813-818.
193. World Health Organization. Zoonotic Non-O157 Shiga Toxin-Producing Escherichia coli (STEC). Report of a WHO Scientific Working Group Meeting. Geneva, Switzerland: World Health Organization, 1998.
194. Wright DJ, Chapman PA, and Siddons CA. Immunomagnetic separation as a sensitive method for isolating Escherichia coli O157 from food samples. Epidemiol. Infect. 1994;113:31-39.
195. Yatsuyanagi J, Saito S, and Ito I. A case of hemolytic-uremic syndrome associated with Shiga toxin 2-producing Escherichia coli O121 infection caused by drinking water contaminated with bovine feces. Jpn. J. Infect. Dis. 2002;55:174-176.
196. Zadik PM, Chapman PA, and Siddons CA. Use of tellurite for the selection of verocytotoxigenic Escherichia coli O157. J. Med. Microbiol. 1993;39:155-158.
197. Zhao T, Doyle MP, Shere J, and Garber L. Prevalence of enterohemorrhagic Escherichia coli O157:H7 in a survey of dairy herds. Appl. Environ. Microbiol. 1995;61:1290-1293.
198. Zwadyk P. Enterobacteriaceae: general characteristics. In: Zinsser Microbiology. Joklik WK, Willet HP, Amos DB, and Wilfert CM (eds). San Mateo, CA: Appleton & Lange, 1992, pp. 538-543.